Ignite Creation Date:
2024-05-05 @ 4:36 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00273624
Status:
WITHDRAWN
Last Update Posted:
2022-08-10
First Post:
2006-01-04
Brief Title:
Olanzapine Augmentation Therapy in Treatment-resistant Depression a Double-blind Placebo-controlled Trial
Sponsor:
University Hospital Freiburg
Organization:
University Hospital Freiburg
Organization Data
Organization:
University Hospital Freiburg
Class:
OTHER
Study ID:
Olanzapine Augmentation
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University Hospital Freiburg
Lead Sponsor Class:
OTHER
Responsible Party:
Claus Normann
Responsible Party Title:
Prof Dr
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
University Hospital Freiburg
Old Name:
None
Old Organization:
None